Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation

Journal of Experimental Medicine

Volumn 207, Issue 12, 2010, Pages 2675-2687

  Ebihara, Takashi ^a,e   Azuma, Masahiro ^a   Oshiumi, Hiroyuki ^a   Kasamatsu, Jun ^a   Iwabuchi, Kazuya ^b   Matsumoto, Kenji ^c   Saito, Hirohisa ^c   Taniguchi, Tadatsugu ^d   Matsumoto, Misako ^a   Seya, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON PROMOTER STIMULATOR 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 3 DEPENDENT NATURAL KILLER ACTIVATING MOLECULE; INTERFERON REGULATORY FACTOR 7; MEMBRANE PROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOPLASM; DENDRITIC CELL; GENE EXPRESSION; LOSS OF FUNCTION MUTATION; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DENDRITIC CELLS; INTERFERON INDUCERS; INTERFERON REGULATORY FACTOR-3; INTERFERON-GAMMA; INTERLEUKIN-15; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; POLY I-C;

EID: 75649141166     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091573     Document Type: Article

References (52)

1. Akazawa, T., T. Ebihara, M. Okuno, Y. Okuda, M. Shingai, K. Tsujimura, T. Takahashi, M. Ikawa, M. Okabe, N. Inoue, et al. 2007a. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc. Natl. Acad. Sci. USA. 104:252-257. doi:10.1073/pnas.0605978104 (Pubitemid 46068018)
2. Akazawa, T., M. Shingai, M. Sasai, T. Ebihara, N. Inoue, M. Matsumoto, and T. Seya. 2007b. Tumor immunotherapy using bone marrow-derived dendritic cells overexpressing Toll-like receptor adaptors. FEBS Lett. 581:3334-3340. doi:10.1016/j.febslet.2007.06.019
3. Azuma, M., R. Sawahata, Y. Akao, T. Ebihara, S. Yamazaki, M. Matsumoto, M. Hashimoto, K. Fukase, Y. Fujimoto, and T. Seya. 2010. The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation. PLoS One. 5:e12550. doi:10.1371/journal.pone.0012550
4. Bertram, L., B.M. Schjeide, B. Hooli, K. Mullin, M. Hiltunen, H. Soininen, M. Ingelsson, L. Lannfelt, D. Blacker, and R.E. Tanzi. 2008. No association between CALHM1 and Alzheimer's disease risk. Cell. 135:993-994, author reply :994-996. doi:10.1016/j.cell.2008.11.030
5. Brandt, C.S., M. Baratin, E.C. Yi, J. Kennedy, Z. Gao, B. Fox, B. Haldeman, C.D. Ostrander, T. Kaifu, C. Chabannon, et al. 2009. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J. Exp. Med. 206:1495-1503. doi:10.1084/jem.20090681
6. Brilot, F., T. Strowig, S.M. Roberts, F. Arrey, and C. Münz. 2007. NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha. J. Clin. Invest. 117:3316-3329. doi:10.1172/JCI31751
7. Cerwenka, A., and L.L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1:41-49. doi:10.1038/35095564
8. Cerwenka, A., A.B. Bakker, T. McClanahan, J. Wagner, J. Wu, J.H. Phillips, and L.L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:721-727. doi:10.1016/S1074-7613(00)80222-8
9. Cerwenka, A., J.L. Baron, and L.L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA. 98:11521-11526. doi:10.1073/pnas.201238598
10. Dreses-Werringloer, U., J.C. Lambert, V. Vingtdeux, H. Zhao, H. Vais, A. Siebert, A. Jain, J. Koppel, A. Rovelet-Lecrux, D. Hannequin, et al. 2008. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell. 133:1149-1161. doi: 10.1016/j.cell.2008.05.048
11. Ebihara, T., H. Masuda, T. Akazawa, M. Shingai, H. Kikuta, T. Ariga, M. Matsumoto, and T. Seya. 2007. Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int. Immunol. 19:1145-1155. doi:10.1093/intimm/dxm073 (Pubitemid 47500638)
12. Fernandez, N.C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:405-411. doi:10.1038/7403
13. Fitzgerald, K.A., S.M. McWhirter, K.L. Faia, D.C. Rowe, E. Latz, D.T. Golenbock, A.J. Coyle, S.M. Liao, and T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496. doi:10.1038/ni921
14. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:327-333. doi:10.1084/jem.20010938
15. Hamerman, J.A., K. Ogasawara, and L.L. Lanier. 2004. Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J. Immunol. 172:2001-2005.
16. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 434:772-777. doi:10.1038/nature03464
17. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168:4531-4537.
18. Huntington, N.D., N. Legrand, N.L. Alves, B. Jaron, K. Weijer, A. Plet, E. Corcuff, E. Mortier, Y. Jacques, H. Spits, and J.P. Di Santo. 2009. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 206:25-34. doi:10.1084/jem.20082013
19. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987-995. doi:10.1038/ni1112
20. Kalinski, P., R.B. Mailliard, A. Giermasz, H.J. Zeh, P. Basse, D.L. Bartlett, J.M. Kirkwood, M.T. Lotze, and R.B. Herberman. 2005. Natural killer-dendritic cell cross-talk in cancer immunotherapy. Expert Opin. Biol. Ther. 5:1303-1315. doi:10.1517/14712598.5.10.1303
21. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K.J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441:101-105. doi:10.1038/nature04734
22. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K.J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988. doi:10.1038/ni1243 (Pubitemid 41486182)
23. Kubin, M.Z., D.L. Parshley, W. Din, J.Y. Waugh, T. Davis-Smith, C.A. Smith, B.M. Macduff, R.J. Armitage, W. Chin, L. Cassiano, et al. 1999. Molecular cloning and biological characterization of NK cell activationinducing ligand, a counterstructure for CD48. Eur. J. Immunol. 29:3466-3477. doi:10.1002/(SICI) 1521-4141(199911)29:11〈3466::AIDIMMU3466〉3.0.CO;2-9
24. Lee, A.E., L.A. Rogers, J.M. Longcroft, and R.E. Jeffery. 1990. Reduction of metastasis in a murine mammary tumour model by heparin and polyinosinic-polycytidylic acid. Clin. Exp. Metastasis. 8:165-171. doi:10.1007/BF00117789
25. Levy, S., and T. Shoham. 2005. The tetraspanin web modulates immunesignalling complexes. Nat. Rev. Immunol. 5:136-148. doi:10.1038/nri1548
26. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity. 26:503-517. doi:10.1016/j.immuni.2007.03.006
27. Masuda, H., Y. Saeki, M. Nomura, K. Shida, M. Matsumoto, M. Ui, L.L. Lanier, and T. Seya. 2002. High levels of RAE-1 isoforms on mouse tumor cell lines assessed by anti-"pan" RAE-1 antibody confer tumor susceptibility to NK cells. Biochem. Biophys. Res. Commun. 290:140-145. doi:10.1006/bbrc.2001.6165
28. Matsumoto, M., and T. Seya. 2008. TLR3: interferon induction by doublestranded RNA including poly(I:C). Adv. Drug Deliv. Rev. 60:805-812. doi:10.1016/j.addr.2007.11.005
29. McCartney, S., W. Vermi, S. Gilfillan, M. Cella, T.L. Murphy, R.D. Schreiber, K.M. Murphy, and M. Colonna. 2009. Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J. Exp. Med. 206:2967-2976. doi:10.1084/jem.20091181
30. Medzhitov, R., and C.A. Janeway Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:295-298. doi:10.1016/ S0092-8674(00)80412-2
31. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 437:1167-1172. doi:10.1038/nature04193
32. Miyake, T., Y. Kumagai, H. Kato, Z. Guo, K. Matsushita, T. Satoh, T. Kawagoe, H. Kumar, M.H. Jang, T. Kawai, et al. 2009. Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways. J. Immunol. 183:2522-2528. doi:10.4049/jimmunol.0901500
33. Mukai, M., F. Imamura, M. Ayaki, K. Shinkai, T. Iwasaki, K. Murakami- Murofushi, H. Murofushi, S. Kobayashi, T. Yamamoto, H. Nakamura, and H. Akedo. 1999. Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA). Int. J. Cancer. 81: 918-922. doi:10.1002/(SICI)1097- 0215(19990611)81:6〈918::AIDIJC13〉3.0.CO;2-E
34. Newman, K.C., and E.M. Riley. 2007. Whatever turns you on: accessorycell- dependent activation of NK cells by pathogens. Nat. Rev. Immunol. 7:279-291. doi:10.1038/nri2057
35. Nomura, M., Z. Zou, T. Joh, Y. Takihara, Y. Matsuda, and K. Shimada. 1996. Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain. J. Biochem. 120:987-995.
36. Ohteki, T., H. Tada, K. Ishida, T. Sato, C. Maki, T. Yamada, J. Hamuro, and S. Koyasu. 2006. Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo. J. Exp. Med. 203:2329-2338. doi:10.1084/jem. 20061297
37. Oshiumi, H., M. Matsumoto, K. Funami, T. Akazawa, and T. Seya. 2003a. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4:161-167. doi:10.1038/ni886 (Pubitemid 36193018)
38. Oshiumi, H., M. Sasai, K. Shida, T. Fujita, M. Matsumoto, and T. Seya. 2003b. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J. Biol. Chem. 278:49751-49762. doi:10.1074/jbc.M305820200
39. Sasai, M., M. Shingai, K. Funami, M. Yoneyama, T. Fujita, M. Matsumoto, and T. Seya. 2006. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J. Immunol. 177:8676-8683.
40. Sato, M., H. Suemori, N. Hata, M. Asagiri, K. Ogasawara, K. Nakao, T. Nakaya, M. Katsuki, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 13:539-548. doi:10.1016/S1074- 7613(00)00053-4
41. Seth, R.B., L. Sun, C.K. Ea, and Z.J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 122:669-682. doi:10.1016/j.cell.2005.08.012
42. Seya, T., and M. Matsumoto. 2009. The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer. Cancer Immunol. Immunother. 58:1175-1184. doi:10.1007/s00262-008-0652-9
43. Sivori, S., M. Falco, M. Della Chiesa, S. Carlomagno, M. Vitale, L. Moretta, and A. Moretta. 2004. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. USA. 101:10116-10121. doi:10.1073/pnas.0403744101
44. Tanaka, H., Y. Mori, H. Ishii, and H. Akedo. 1988. Enhancement of metastatic capacity of fibroblast-tumor cell interaction in mice. Cancer Res. 48:1456-1459.
45. Tsuji, S., J. Uehori, M. Matsumoto, Y. Suzuki, A. Matsuhisa, K. Toyoshima, and T. Seya. 2001. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J. Biol. Chem. 276:23456-23463. doi:10.1074/jbc.M103162200 (Pubitemid 33654215)
46. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9:503-510. doi:10.1038/ni1582
47. Xu, L.G., Y.Y. Wang, K.J. Han, L.Y. Li, Z. Zhai, and H.B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell. 19:727-740. doi:10.1016/j.molcel.2005.08.014
48. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003a. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 301:640-643. doi:10.1126/science.1087262 (Pubitemid 36927946)
49. Yamamoto, M., S. Sato, H. Hemmi, S. Uematsu, K. Hoshino, T. Kaisho, O. Takeuchi, K. Takeda, and S. Akira. 2003b. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4:1144-1150. doi:10.1038/ni986 (Pubitemid 37428043)
50. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737. doi:10.1038/ni1087
51. Zanoni, I., M. Foti, P. Ricciardi-Castagnoli, and F. Granucci. 2005. TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. J. Immunol. 175:286-292.
52. Zou, Z., M. Nomura, Y. Takihara, T. Yasunaga, and K. Shimada. 1996. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules. J. Biochem. 119:319-328.